University at Buffalo - The State University of New York
Skip to Content

Interdisciplinary research teams at UB’s New York State Center of Excellence in Bioinformatics & Life Sciences (CBLS) and our partner institutions have a rich history of innovation, spanning the path from discovery to translational applications including diagnostics, therapeutics, and medical devices. Today, we are at the forefront of some of the most impactful, fastest-growing areas of study in the world. 


As the nation’s leading cause of death, cardiovascular disease is the subject of important research at the CBLS.

The study of the human genome — the complete set of genetic information for human beings — is perhaps the largest collaborative research project ever undertaken.
The broad field of informatics encompasses the development of computing technology for the powerful and wide-ranging analysis of data for a variety of applications. 

Researchers at the CBLS are committed to fighting neurodegenerative diseases, which damage or destroy neurons in the brain.


Combining UB’s nationally recognized faculty and staff, state-of-the-art equipment, and high-performance computing resources.


Our proximity to high-level clinical environments provides the ideal setting to conduct collaborative study.


The Center for Protein Therapeutics (CPT) works with leading pharmaceutical companies to advance the development of next-generation protein drugs.


By studying stem cell biology and regenerative medicine, we hope to provide therapies for cancer, diabetes, and many other diseases and conditions.


The study of the growth and development of new biological tissues holds tremendous promise for the future of medicine.


The Translational Pharmacology Research Core (TPRC) facilitates and expedites the translation of research into approved drugs.